The European Chemicals Agency’s Biocidal Products Committee (BPC) met in Helsinki on 25 September 2024 to discuss several important evaluations and product authorisations. Key topics included post-approval data concerning icaridin, the authorisation of a Transfluthrin-based product family, and updates to procedures for Union authorisations. These decisions aim to ensure regulatory consistency for biocidal products across the EU.
Key Decisions on Active Substances
During the meeting, Denmark, acting as the evaluating competent authority, presented post-approval data for icaridin, a commonly used insect repellent in product-type 19. The BPC reviewed analytical methods and addressed a correction in the environmental impact predictions for the metabolite icaridin-acid. This correction is crucial to maintaining consistent environmental assessments across the EU.
Union Authorisations for Biocidal Products
The BPC also approved Union authorisations for several product families. Notably, a biocidal product family containing Transfluthrin, designed for indoor use by non-professional users to combat moths, mosquitoes, and flies, received authorisation. These products include liquids used in electric vaporisers. The Netherlands acted as the evaluating authority.
Additionally, a biocidal product family containing L-(+)-lactic acid, intended for use in veterinary hygiene (product-type 3) as a post-milking disinfectant, was authorised. The ready-to-use product is effective against bacteria and yeast, with the Netherlands also overseeing this evaluation.
In contrast, the BPC rejected the authorisation of a Chlorocresol-based biocidal product family intended for veterinary hygiene. Germany, the evaluating authority, led the decision following an in-depth review of its efficacy and safety.
Supporting the Renewal of Union Authorisations
With the first Union authorisations set to expire in June 2026, the BPC discussed key procedural documents to guide the renewal process. These include general procedures for renewals, guidelines for translating product characteristics, and criteria for determining whether a ‘full’ or ‘limited’ evaluation is required for renewal applications.
Future Implications
As the BPC continues to evaluate and refine its procedures, these decisions reflect its commitment to maintaining high standards of product safety and environmental protection. The committee’s recommendations will be available on the ECHA website, providing guidance to stakeholders navigating the EU’s regulatory framework for biocidal products.
